Connect your AI

WHWK WHWK Investment Purchases

Investment Purchases at other companies

Eli LillyLLY

$297M+50.8%

Gilead SciencesGILD

$525M—

IDEAYA Biosciences, Inc.IDYA

$42.61M-59.5%

CytomX TherapeuticsCTMX

$242.78M+1,127%

Other financials

Income statement

Revenue--100%

Gross profit--100%

Operating income-$23.5M-54.6%

Net income-$22.2M-130%

EPS (diluted)-$0.32-117%

Balance sheet

Cash & equivalents$34.8M-84.7%

Total debt$833.0K-34.3%

Total equity$116.2M-47.6%

Total assets$127.2M-45.6%

Cash flow

Operating cash flow-$22.2M-87.2%

CapEx--100%

Free cash flow-$22.2M-78.9%

Valuation

Market cap$226.49M+131%

Profitability

Gross margin89.4%+1.0pp

Operating margin-1,601.1%-1,985pp

Net margin-288.3%+61.6pp

FCF margin-1,371.4%-1,730pp

Returns & leverage

Return on equity-68.5%-86.2pp

Debt / equity0×0.0×

Current ratio11.4×-7.6×

Where this comes from

Reported directly by WHWK in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt.

The official record: WHWK’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about WHWK's investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is WHWK's investment purchases?: WHWK (WHWK) reported investment purchases of $19.19M in Q1 2026.
What does investment purchases mean?: Cash spent purchasing investment securities across all categories.